AxoGen (AXGN) Reports In-Line Q3 EPS

AxoGen (NASDAQ: AXGN) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $16 million versus the consensus estimate of $15.59 million.

Guidance:

Sees FY 2017 revenues up 40%

Sees FY 2018 revenues up 40%

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Nike names former Pfizer CFO David Denton as new finance chief